The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Medical Treatment of Chronic Pancreatitis

만성췌장염의 내과적 치료

  • Yoo, Kyo-Sang (Division of Gastroenterology, Department of Internal Medicine, Hanyang University College of Medicine)
  • 유교상 (한양대학교 의과대학 내과학교실)
  • Published : 2012.07.01
⟨ Previous Next ⟩

Abstract

Chronic pancreatitis is an inflammatory disease characterized by the progressive destruction of pancreatic tissue and resulting in pancreatic exocrine and endocrine insufficiency. Although a lot of efforts have been made in managing chronic pancreatitis, treatment of chronic pancreatitis is still challenging and remains mostly empirical. Medical treatment of chronic pancreatitis focuses on chronic abdominal pain, pancreatic exocrine insufficiency and also pancreatic endocrine insufficiency. Chronic disabling abdominal pain is the main symptom of chronic pancreatitis, which could be managed by analgesics and non-enteric coated pancreatic enzymes as well as adjunctive agents such as antidepressants, duolexitine and pregabalin. Pancreatic exocrine insufficiency is commonly associated with weight loss, steatorrhea and malnutrition. Adequate pancreatic enzyme replacement therapy can significantly improve not only exocrine insufficiency related symptoms but also nutritional status. Several problems affecting the efficacy of pancreatic enzyme replacement can be avoided by the use of enteric-coated enzyme microspheres with or without proton pump inhibitors.

Keywords

References

  1. Trikudanathan G, Navaneethan U, Vege SS. Modern treatment of patients with chronic pancreatitis. Gastroenterol Clin North Am 2012;41:63-76. https://doi.org/10.1016/j.gtc.2011.12.009
  2. Nair RJ, Lawler L, Miller MR. Chronic pancreatitis. Am Fam Physician 2007;76:1679-1688.
  3. Braganza JM, Lee SH, McCloy RF, McMahon MJ. Chronic pancreatitis. Lancet 2011;377:1184-1197. https://doi.org/10.1016/S0140-6736(10)61852-1
  4. Gupta V, Toskes PP. Diagnosis and management of chronic pancreatitis. Postgrad Med J 2005;81:491-497. https://doi.org/10.1136/pgmj.2003.009761
  5. Chauhan S, Forsmark CE. Pain management in chronic pancreatitis: a treatment algorithm. Best Pract Res Clin Gastroenterol 2010;24:323-335. https://doi.org/10.1016/j.bpg.2010.03.007
  6. Thuluvath PJ, Imperio D, Nair S, Cameron JL. Chronic pancreatitis: long-term pain relief with or without surgery, cancer risk, and mortality. J Clin Gastroenterol 2003;36:159-165. https://doi.org/10.1097/00004836-200302000-00014
  7. Gachago C, Draganov PV. Pain management in chronic pancreatitis. World J Gastroenterol 2008;14:3137-3148 https://doi.org/10.3748/wjg.14.3137
  8. Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associatedcomplications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut 2011;60:77-84. https://doi.org/10.1136/gut.2010.213835
  9. Ammann RW, Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999;116:1132-1140. https://doi.org/10.1016/S0016-5085(99)70016-8
  10. Ammann RW, Akovbiantz A, Largiader F, Schueler G. Course and outcome of chronic pancreatitis: longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology 1984;86(5 Pt 1):820-828.
  11. Lee DK. Natural course and medical treatment of chronic pancreatitis. Korean J Gastroenterol 2005;46:345-351.
  12. Lieb JG 2nd, Forsmark CE. Review article: pain and chronic pancreatitis. Aliment Pharmacol Ther 2009;29:706-719. https://doi.org/10.1111/j.1365-2036.2009.03931.x
  13. Hayakawa T, Kondo T, Shibata T, Sugimoto Y, Kitagawa M. Chronic alcoholism and evolution of pain and prognosis in chronic pancreatitis. Dig Dis Sci 1989;34:33-38. https://doi.org/10.1007/BF01536151
  14. Strum WB. Abstinence in alcoholic chronic pancreatitis: effect on pain and outcome. J Clin Gastroenterol 1995;20:37-41. https://doi.org/10.1097/00004836-199501000-00010
  15. Andriulli A, Botteri E, Almasio PL, Vantini I, Uomo G, Maisonneuve P; ad hoc Committee of the Italian Association for the Study of the Pancreas. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas 2010;39:1205-1210. https://doi.org/10.1097/MPA.0b013e3181df27c0
  16. Law R, Parsi M, Lopez R, Zuccaro G, Stevens T. Cigarette smoking is independently associated with chronic pancreatitis. Pancreatology 2010;10:54-59. https://doi.org/10.1159/000225927
  17. Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009;169:1035-1045. https://doi.org/10.1001/archinternmed.2009.125
  18. Wilder-Smith CH, Hill L, Osler W, O'Keefe S. Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis. Dig Dis Sci 1999;44:1107-1116. https://doi.org/10.1023/A:1026607703352
  19. Olesen SS, Bouwense SA, Wilder-Smith OH, van Goor H, Drewes AM. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology 2011;141:536-543. https://doi.org/10.1053/j.gastro.2011.04.003
  20. Layer P, Jansen JB, Cherian L, Lamers CB, Goebell H. Feedback regulation of human pancreatic secretion: effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes. Gastroenterology 1990;98(5 Pt 1):1311-1319.
  21. American Gastroenterological Association Medical Position Statement: treatment of pain in chronic pancreatitis. Gastroenterology 1998;115:763-764. https://doi.org/10.1016/S0016-5085(98)70156-8
  22. Brown A, Hughes M, Tenner S, Banks PA. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis. Am J Gastroenterol 1997;92:2032-2035.
  23. Winstead NS, Wilcox CM. Clinical trials of pancreatic enzyme replacement for painful chronic pancreatitis: a review. Pancreatology 2009;9:344-350. https://doi.org/10.1159/000212086
  24. Bhardwaj P, Garg PK, Maulik SK, Saraya A, Tandon RK, Acharya SK. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009;136:149-159. e142. https://doi.org/10.1053/j.gastro.2008.09.028
  25. Grigsby B, Rodriguez-Rilo H, Khan K. Antioxidants and chronic pancreatitis: theory of oxidative stress and trials of antioxidant therapy. Dig Dis Sci 2012;57:835-841. https://doi.org/10.1007/s10620-012-2037-3
  26. Malfertheiner P, Mayer D, Buchler M, Dominguez-Munoz JE, Schiefer B, Ditschuneit H. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995;36:450-454. https://doi.org/10.1136/gut.36.3.450
  27. Uhl W, Anghelacopoulos SE, Friess H, Buchler MW. The role of octreotide and somatostatin in acute and chronic pancreatitis. Digestion 1999;60(Suppl 2):23-31.
  28. Sikkens EC, Cahen DL, Kuipers EJ, Bruno MJ. Pancreatic enzyme replacement therapy in chronic pancreatitis. Best Pract Res Clin Gastroenterol 2010;24:337-347. https://doi.org/10.1016/j.bpg.2010.03.006
  29. Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 2003;27:235-238. https://doi.org/10.1097/00006676-200310000-00007
  30. Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994;107:1481-1487. https://doi.org/10.1016/0016-5085(94)90553-3
  31. Lee JK. Guideline andcurrent state of diagnosis of chronic pancreatitis in Korea. Korean J Pancreatobiliary 2008;13:29-37.
  32. Dominguez-Munoz JE. Pancreatic exocrine insufficiency: diagnosis and treatment. J Gastroenterol Hepatol 2011;26 (Suppl 2):12-16.
  33. Taylor JR, Gardner TB, Waljee AK, Dimagno MJ, Schoenfeld PS. Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency. Aliment Pharmacol Ther 2010;31:57-72. https://doi.org/10.1111/j.1365-2036.2009.04157.x
  34. Dominguez-Munoz JE, Iglesias-Garca J, Vilarino-Insua M, Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007;5:484-488. https://doi.org/10.1016/j.cgh.2007.01.004
  35. Dominguez-Munoz JE, Hieronymus C, Sauerbruch T, Malfertheiner P. Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol 1995;90:1834-1837.
  36. Loser C, Mollgaard A, Fölsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996;39:580-586. https://doi.org/10.1136/gut.39.4.580
  37. Dominguez-Munoz JE. Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes? Clin Gastroenterol Hepatol 2011;9:541-546. https://doi.org/10.1016/j.cgh.2011.02.027
  38. Lohr JM, Hummel FM, Pirilis KT, Steinkamp G, Körner A, Henniges F. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency. Eur J Gastroenterol Hepatol 2009;21:1024-1031. https://doi.org/10.1097/MEG.0b013e328328f414
  39. Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 1998;42:92-96. https://doi.org/10.1136/gut.42.1.92
  40. Holtmann G, Kelly DG, Sternby B, DiMagno EP. Survival of human pancreatic enzymes during small bowel transit: effect of nutrients, bile acids, and enzymes. Am J Physiol 1997;273(2 Pt 1):G553-G558.
  41. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut 2005;54(Suppl 6): vi1-vi28.
  42. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973;288:813-815. https://doi.org/10.1056/NEJM197304192881603
  43. Dominguez-Munoz JE, Iglesias-García J, Iglesias-Rey M, Figueiras A, Vilarino-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther 2005;21:993-1000. https://doi.org/10.1111/j.1365-2036.2005.02390.x
  44. DiMagno EP, Malagelada JR, Go VL, Moertel CG. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two dosage schedules. N Engl J Med 1977;296:1318-1322. https://doi.org/10.1056/NEJM197706092962304
  45. Wier HA, Kuhn RJ. Pancreatic enzyme supplementation. Curr Opin Pediatr 2011;23:541-544. https://doi.org/10.1097/MOP.0b013e32834a1b33
  46. Whitcomb DC, Lehman GA, Vasileva G, et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial. Am J Gastroenterol 2010;105:2276-2286. https://doi.org/10.1038/ajg.2010.201
  47. Gubergrits N, Malecka-Panas E, Lehman GA, et al. A 6-month, open-label clinical trial of pancrelipase delayedrelease capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther 2011;33:1152-1161. https://doi.org/10.1111/j.1365-2036.2011.04631.x
  48. Dominguez-Munoz JE, Iglesias-García J. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy? JOP 2010;11:158-162.
  49. Frulloni L, Falconi M, Gabbrielli A, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 2010; 42(Suppl 6):S381-S406.
  50. Dominguez-Munoz JE, Iglesias-García J, Iglesias-Rey M, Vilariño-Insua M. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut 2006;55:1056-1057. Erratum in: Gut 201261:327.
  51. Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology 2011;11:279-294. https://doi.org/10.1159/000329188
  52. American Diabetes Association. Standards of medical care in diabetes: 2011. Diabetes Care 2011;34(Suppl 1):S11-S61.

Cited by

  1. Recent Advances in Management of Chronic Pancreatitis vol.66, pp.3, 2012, https://doi.org/10.4166/kjg.2015.66.3.144
  2. 만성 췌장염의 한약치료에 대한 최신 임상연구 동향 - CNKI검색을 중심으로 vol.38, pp.1, 2012, https://doi.org/10.22246/jikm.2017.38.1.48